Lobbying client

ZAVANTE THERAPEUTICS, INC.

Biopharmaceutical company focused on antibacterial agents to treat serious infections.

Filings
4
Filed by
1
Reported in-house
—
Reported by firms
$30,000

Filings

4 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination (No Activity)
3rd Quarter 2015
THE MCMANUS GROUP $10,000 reported
2nd Quarter - Report
2nd Quarter 2015
THE MCMANUS GROUP $10,000 reported
1st Quarter - Report
1st Quarter 2015
THE MCMANUS GROUP $10,000 reported
Registration
1st Quarter 2015
THE MCMANUS GROUP — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE MCMANUS GROUP 3 $30,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 3

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 512 114th 2
H.R. 6 114th 1

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.